Company name Riverain Technologies
Founded 2004
Head office Miamisburg, United States
Website https://www.riveraintech.com/
Contact support@riveraintech.com

Products by this company

Logo
Subspeciality: Chest
Modality: CT

multiple time-point analysis

Nodule tracking for differential measurements. Utilizing ClearRead CT Detect, ClearRead CT Compare tracks nodules and provides nodule volumetric changes over time for solid, part-solid, and ground ...

Information source:
Vendor
Certification verified:
No
Logo
Subspeciality: Chest
Modality: CT

lung nodule detection

Riverain’s ClearRead CT Detect detects lung nodules in CT images.

Information source:
Vendor
Certification verified:
No
Logo
Subspeciality: Chest
Modality: CT

vessel suppression

Riverain’s ClearRead CT Vessel Suppress is powered by machine learning and advanced modeling and suppresses vascular structures. The vessel suppression algorithm works with contrast and non-contrast ...

Information source:
Vendor
Certification verified:
No
Logo
Subspeciality: Chest
Modality: X-ray

bone suppression

ClearRead Bone Suppress removes ribs and clavicles from a standard chest X-ray, providing a soft tissue image, allowing clinicians to see more and detect more.

Information source:
Vendor
Certification verified:
No
Logo
Subspeciality: Chest
Modality: X-ray

multiple time-point analysis

ClearRead Compare is an image registration and enhancement application that accentuates interval change between current and prior chest X-ray exams by forming a subtraction image.

Information source:
Vendor
Certification verified:
No
Logo
Subspeciality: Chest
Modality: X-ray

line and tube identification

ClearRead XRay identifies and highlights lines and tubes on portable chest X-ray images. Radiologists can minimise imaging adjustments and decrease reading time.

Information source:
Vendor
Certification verified:
No
Logo
Subspeciality: Chest
Modality: X-ray

lung nodule detection

ClearRead Detect identifies regions-of-interest on the bone suppressed soft tissue image that may be early-stage lung cancer.

Information source:
Vendor
Certification verified:
No